JARDIANCE MET 12.5MG/500MG Tablets (Empagliflozin + Metformin)
JARDIANCE MET 12.5MG/500MG TABLETS contain Empagliflozin 12.5mg and Metformin 500mg, a prescription diabetes medicine used with diet and exercise to improve blood glucose control in type 2 diabetes.
JARDIANCE MET 12.5MG/500MG TABLETS
JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN 12.5MG + METFORMIN 500MG): Comprehensive Guide and Benefits
Introduction to JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN 12.5MG + METFORMIN 500MG)
JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN 12.5MG + METFORMIN 500MG): A Diabetes Medication (SGLT2 Inhibitor + Biguanide Combination)
JARDIANCE MET 12.5MG/500MG TABLETS contain a fixed-dose combination of Empagliflozin 12.5mg and Metformin Hydrochloride 500mg, belonging to the oral antidiabetic medication class. It is prescribed along with diet and exercise to help improve blood glucose control in adults with type 2 diabetes mellitus.
Empagliflozin is an SGLT2 inhibitor that helps remove excess glucose through urine, while Metformin is a biguanide that reduces glucose production in the liver and improves insulin sensitivity. JARDIANCE MET 12.5MG/500MG TABLETS are prescription-only medicines and should be used under the supervision of a healthcare professional with appropriate monitoring.
Key Benefits of JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN + METFORMIN)
Helps improve blood glucose control in adults with type 2 diabetes mellitus.
Provides dual-action glucose regulation through two complementary mechanisms.
Helps reduce excess glucose production and increase glucose elimination.
Supports improved insulin sensitivity and glucose utilization.
Offers a convenient combination therapy option when prescribed by a doctor.
How JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN + METFORMIN) Works
JARDIANCE MET combines two antidiabetic medicines with different mechanisms of action. Empagliflozin inhibits sodium-glucose cotransporter-2 (SGLT2) in the kidneys, reducing glucose reabsorption and increasing glucose removal through urine. Metformin decreases glucose production in the liver, improves insulin sensitivity, and helps regulate glucose metabolism. Together, these actions help lower elevated blood glucose levels in individuals with type 2 diabetes.
Usage Instructions for JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN + METFORMIN)
Take JARDIANCE MET 12.5MG/500MG TABLETS exactly as prescribed by your doctor.
Swallow the tablet whole with water; do not crush, chew, or break it.
Take the medicine at the recommended time, preferably with food if advised.
Monitor blood glucose levels and kidney function as recommended.
Do not stop or change the dosage without consulting your healthcare provider.
Medicinal Advantages of JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN + METFORMIN)
Helps maintain better blood sugar control as part of type 2 diabetes management.
Combines two established oral antidiabetic medicines in one formulation.
Helps reduce glucose levels through insulin-independent and insulin-sensitive pathways.
Supports individualized diabetes treatment strategies.
May improve treatment convenience by reducing the number of separate medicines required.
NOTE: JARDIANCE MET 12.5MG/500MG TABLETS are prescription-only medicines. They are not intended for type 1 diabetes treatment and require medical supervision, especially in patients with kidney problems, dehydration risk, or metabolic disorders.
Off-Label Uses of JARDIANCE MET 12.5MG/500MG TABLETS (EMPAGLIFLOZIN + METFORMIN)
Healthcare professionals may occasionally prescribe components of this combination for uses outside approved indications based on clinical evaluation and patient-specific requirements.
Selected insulin resistance-related conditions under specialist guidance.
Individualized metabolic management approaches.
Specialist-directed glucose regulation strategies.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Take JARDIANCE MET regularly according to your prescription.
Maintain a balanced diet and regular physical activity.
Monitor blood sugar levels as recommended.
Maintain adequate hydration during treatment.
Inform your doctor before surgery or prolonged fasting.
Report symptoms of urinary infections, dehydration, or unusual weakness.
Precautions
Cardiovascular Health
Patients with cardiovascular disease or risk factors should inform their doctor before starting treatment. Regular monitoring of heart health and diabetes control may be required.
Liver & Kidney Function
Kidney function should be assessed before and during treatment when clinically appropriate. Metformin may require dose adjustment or avoidance in severe kidney impairment.
Pregnancy & Breastfeeding
JARDIANCE MET should be used during pregnancy only when specifically recommended by a healthcare professional. Breastfeeding individuals should consult their doctor before use.
Drug Interactions
JARDIANCE MET may interact with insulin, sulfonylureas, diuretics, contrast imaging agents, and medicines affecting kidney function. Inform your doctor about all medications and supplements.
Existing Medical Conditions
Inform your healthcare provider if you have kidney disease, liver disease, heart failure, dehydration, recurrent urinary infections, or a history of diabetic ketoacidosis.
Storage Instructions
Store below 30°C.
Keep tablets in the original blister packaging.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Do not use after the expiry date.
Frequently Asked Questions (FAQs)
Q: What is JARDIANCE MET 12.5MG/500MG TABLETS used for?
A: JARDIANCE MET 12.5MG/500MG TABLETS are used with diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus.
Q: What are the active ingredients in JARDIANCE MET?
A: The active ingredients are Empagliflozin 12.5mg and Metformin Hydrochloride 500mg.
Q: Is JARDIANCE MET an insulin medicine?
A: No. It is an oral antidiabetic combination containing an SGLT2 inhibitor and a biguanide medicine.
Q: How does JARDIANCE MET lower blood sugar?
A: Empagliflozin helps remove excess glucose through urine, while Metformin reduces liver glucose production and improves insulin sensitivity.
Q: Can JARDIANCE MET cause low blood sugar?
A: Low blood sugar risk may increase when it is combined with insulin or certain other diabetes medicines.
Q: Should JARDIANCE MET be taken with food?
A: It should be taken according to your doctor’s instructions. Taking it with food may help improve stomach tolerance.
Q: Is JARDIANCE MET available without prescription?
A: No. JARDIANCE MET is a prescription medicine and should only be used under medical supervision.
Product Tags
JARDIANCE MET 12.5MG/500MG TABLETS, Empagliflozin 12.5mg Metformin 500mg, Empagliflozin Tablet, Metformin Tablet, SGLT2 Inhibitor, Biguanide Medicine, Diabetes Medication, Type 2 Diabetes Treatment, Blood Sugar Control Tablet, Antidiabetic Medicine, Oral Diabetes Medicine, Glycemic Control Therapy, JARDIANCE MET Tablet, Empagliflozin Metformin Combination, Prescription Diabetes Medicine, Glucose Lowering Medicine, Diabetic Care Tablet, Type 2 Diabetes Management, Diabetes Treatment Tablet, SGLT2 Diabetes Therapy.
